Microfluidic Production of Liposomes for Controlled Drug Encapsulation

Liposome vesicles traditionally synthesized by bulk methods are generally not a uniform and reproducible product. Consequently, these particles do not represent a very attractive solution for the pharmaceutical industry; particularly in the field of smart drug delivery where narrow distributions, small particle sizes and controllable and reproducible synthesis are desired. Nowadays, new microfluidic continuous flow technologies offer an attractive solution for the synthesis of small and narrow size particle distributions.

This webinar hosted by Dr. Damiano Rossi presented our latest research and encapsulation methods tested using Dolomite Liposome Synthesis Systems.

1) Introduction: 0:00 - 3:20
2) Why use microfluidic technology? 3:20 - 3:55
3) Batch synthesis & flow microfluidic synthesis: 3:55 - 6:15
4) Liposome particle production & set-up: 6:15 - 10:45
5) Dolomite single channel & Telos high-throughput systems: 10:45 - 14:40
6) Giant liposomes & other particles: 14:40 - 16:30
7) Summary: 16:30 - 17:35
8) Dolomite liposome synthesis system overview: 17:35 - 26:00
9) Flow control center overview: 26:00 - 30:30
10) Ending & additional information: 30:30 - 31:35

To find out more please do not hesitate to contact us at: [email protected]
Or visit our website: dolomite-microfluidics.com